Clinical Trial Update: Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding [NA]

View source ↗

Summary

A clinical trial investigating rifaximin for treatment of cirrhotic gastroesophageal variceal bleeding; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Esophageal Variceal Bleeding
• Gastrointestinal Hemorrhage

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cirrhosis, Esophageal and Gastric Varices | NA | Status: UNKNOWN